ArticleBMC cancer2026

Serum amyloid A kinetics predicts outcomes to PD-1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma.

Zhiting Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.